BBLG
NASDAQ · Biotechnology
Bone Biologics Corp
$1.40
+0.04 (+2.56%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,413.6% upside
Low Target
$14.35
Average Target
$21.19
High Target
$22.63
Current Price
$1.40
Current
$1.40
$1.40
Target
$21.19
$21.19
$14.35
$21.19 avg
$22.63
Scenario Analysis
Bear Case
$14.35
925.0%
Low target
Base Case
$21.19
+1,413.6%
Avg target
Bull Case
$22.63
+1,516.4%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$19.63
-92.9% from high
52-Week Low
$12.26
+-88.6% from low
Target vs 52W High
$21.19
+7.9% vs high
Next Earnings Report
Feb 24, 2026 · After Market Close
8d
until earnings
EPS Est: $-0.35
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |